IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 1/2 biotech developing targeted therapies for solid tumors.
Industry: Health Care
Latest Trade: $0.90 0.00 (0.0%)
First Day Return: +60.8%
Return from IPO: -95.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/15/2021 |
Offer Price | $20.00 |
Price Range $18.00 - $19.00 | |
Offer Shares (mm) | 11.5 |
Deal Size ($mm) | $230 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/04/2021 |
Offer Price | $20.00 |
Price Range $18.00 - $19.00 | |
Offer Shares (mm) | 11.5 |
Deal Size ($mm) | $230 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | Redwood City, CA, United States |
Founded | 2015 |
Employees | 63 |
Website www.boltbio.com |